Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Vascular Biogenics Ltd.
199
Vascular Biogenics Ltd.
VBL Therapeutics, is a clinical stage biopharmaceutical company focused on discovery, development and commercialization of first-in-class treatments for cancer.
Suggest edits
Raised
$24.5M
Follow us
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$2,489,422
Grant - 2017
Israel Innovation Authority
$22,000,000
Secondary market - 2016
Team Size
10+
Employees
I work here
Location
Israel
Headquarters
Explore Israel
$2,489,422
Grant
GEN
VBL Wins $2.5M Grant to Progress Pivotal-Stage Anticancer Gene Therapy Genetic Engineering & Biotechnology News - Biotec...
